[翻译文章] 儿科血液瘤患者的药物调和:一个多中心研究
Margarita Cuervas-Mons Vendrell1, Dolores Pilar Iturgoyen Fuentes1, Miquel Villaronga Flaque2
1Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
概括
儿科瘤血液病患者容易出现药物调和错误,其中遗漏是最常见的. 家庭药物的数量增加了错误的风险,强调了在住院期间需要仔细调整药物的需要.
科学领域:
- 儿科血液学/瘤学
- 患者安全 患者安全
- 药物管理 药物管理
背景情况:
- 药物调和对于在护理过渡期间的患者安全至关重要.
- 儿科瘤血液病患者是一个复杂的群体,需要大量的药物治疗.
- 了解这个人群中调和错误的流行率至关重要.
研究的目的:
- 为了确定医院入院时儿科瘤血液病患者中药物调和错误的患病率.
- 为了比较成年人群对错误的易感性.
- 为了确定与这些错误相关的患者特征.
主要方法:
- 这是一项为期12个月的前性多中心研究.
- 在入院时对157名儿科瘤血液病患者进行了药物调整.
- 收集关于差异,错误类型和患者因素的数据.
主要成果:
- 在157名患者中的96名患者中发现了药物异常.
- 48.9%的差异被归类为协调错误.
- 错过药物是最常见的错误类型.
- 服用4种以上家庭用药的患者的错误风险增加了2.1倍.
结论:
- 在儿科瘤血液病患者中,药物调和错误很普遍.
- 家庭药物的数量是调和错误的重要风险因素.
- 遗漏药物是主要类型的错误,需要有针对性的干预措施.
相关概念视频
Bone Marrow Sampling and Transplants
356
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


